Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-01-26T19:48:08.407Z Has data issue: false hasContentIssue false
  • English
  • Français

Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni

Published online by Cambridge University Press:  15 May 2009

M. L. Hänninen
M. L. Hänninen
Affiliation:
College of Veterinary Medicine, Department of Food and Environmental Hygiene, P.O. Box 6, SF-00581 Helsinki, Finland.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Infant mice were used for the evaluation of the efficacy of bismuth subaslicylate (BSS) in the prevention the growth of Campylobacter jejuni in the intestine. The MIC90 of ten C. jejuni strains was 900 μg/ml. Of three dosage regimens tested, continuous treatment before and after the bacterial challenge, mimicking the way BSS is used in the prevention of traveller's diarrhoea, was the most effective. Growth inhibition was dose dependent; the high dose of 2000 μg per day was more effective than 300 μg per day. After cessation of treatment, campylobacter counts increased to the same level as in the control animals.

Type
Research Article
Information
Epidemiology & Infection , Volume 104 , Issue 3 , June 1990 , pp. 397 - 404
Copyright
Copyright © Cambridge University Press 1990

References

REFERENCES

1.Pitkänen, T.Traveler's diarrhea caused by Campylobacter jejuni. Ann Clin Res 1982; 14: p 111–13.Google ScholarPubMed
2.Svedhem, Å, Kaiser, B. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis 1980; 142: 353–59.CrossRefGoogle ScholarPubMed
3.Walder, M. Epidemiology of Campylobacter enteritis. Scand J Infect Dis 1982; 14: 27–33.CrossRefGoogle ScholarPubMed
4.Gorbach, SL, Kean, BH, Evans, DG et al. , Traveler's diarrhea and toxigenic Escherichiacoli. N Eng J Med 1975; 292: 933–6.CrossRefGoogle Scholar
5.DuPont, HL, Sullivan, P, Evans, GD et al. , Prevention of traveler's diarrhea. J Am Med Ass 1980; 243: 237–41.CrossRefGoogle ScholarPubMed
6.Steffen, R, DuPont, HL, Heusser, R, Helminger, A, Witassek, F, Manhart, MD, Schár, M. Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate. Antimicrobial Agents Chemother 1986; 29: 625–7.CrossRefGoogle ScholarPubMed
7.Blaser, MJ, Berkowitz, ID, LaForce, FM, Cravens, J, Reller, LB, Wang, WLL. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med 1979; 91: 179–85.CrossRefGoogle ScholarPubMed
8.Cornick, MA., Silva, M, Gorbach, SL. In vitro activity of bismuth subsalicylate. In: Abstracts of the Annual Meeting of the American Society of Microbiology. Miami: American Society of Microbiology. 1988: 7.Google Scholar
9.McNulty, CAM, Dent, J, Wise, R. Susceeptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents In: Pearson, AD, Skirrow, MB, Lior, H, Rowe, B., eds. Campylobacter III. Proceedings of the Third International Workshop on Campylobacter Infections, Ottawa, 7–10 July 1985. London: Public Health Laboratory Service, 1985: 169–70.Google Scholar
10.Marshall, BJ, Warren, JR, Blincow, ED et al. , Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; II: 1437–42.CrossRefGoogle Scholar
11.Armstrong, JA, Wee, SH, Goodwin, CS, Wilson, DH. Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitroan ultrastructural study. J. Med Microbiol 1987; 24: 343–50.CrossRefGoogle Scholar
12.Lee, A, O'Rourke, JL, Barrington, PJ, Trust, TJ. Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect Immun 1986; 51: 536–46.CrossRefGoogle ScholarPubMed
13.Cornick, MA, Silva, M, Gorbach, SL, Effect of Bismuth subsalicylate on normal bowel flora. In: Abstracts Society of The Annual Meeting of The American Society of Microbiology. Miami: American Society of Microbiology, 1988: 7.Google Scholar
14.Abimiku, AG, Dolby, JM, Borriello, SP. Comparison of different vaccines and induceced immune responese against Campylobacter jejuni colonization in the infant mouse. Epidemiol Infect 1989; 102: 271–80.CrossRefGoogle Scholar
15.Field, LH, L'nderwood, JL, Pope, LM, Berry, LJ, Intestinal colonization of neonatal animals by Campylobacter fetus subsp. jejuni. Infect Immun 1981; 33: 884–92.CrossRefGoogle ScholarPubMed
16.Hänninen, ML. Effect of endotoxin on the colonisation of Campylobacter jejuni in infant mice. J Med Microbiol 1989; 30: 199–206.CrossRefGoogle ScholarPubMed
17.Kazmi, SU, Roberson, BS, Stern, NJ. Animal-passed, virulence enhanced Campylobacter jejuni causes enteritis in neonatal mice. Curr Microbiol 1984; 11: 159–64.CrossRefGoogle Scholar
18.Dolby, JM, Newell, DG. The protection of infant mice from colonization with Campylobacter jejuni by vaccination of the dams. J Hyg 1986; 96: 143–51.CrossRefGoogle ScholarPubMed
19.Walker, RI, Caldwell, MB, Lee, CI, Guerry, P, Trust, TJ, Ruiz-Palacios, M. Pathophysiology of Campylobacter enteritis. Microbiol Rev 1986; 50: 81–94.CrossRefGoogle ScholarPubMed